• 

  November 4, 2025

  Managing a Rare Cancer-What You Need to Know

  Charles H. Weaver, MD

• 

  August 9, 2024

  Ask The Expert From Memorial Sloan Kettering About The Treatment of Sarcomas

  Charles H. Weaver, MD

• 

  March 25, 2024

  Fyarro for Malignant Perivascular Epithelioid Cell Tumor (PEComa)

  Charles H. Weaver, MD

• 

  November 28, 2023

  Treatment of Desmoid Tumors

  Charles H. Weaver, MD

• 

  September 11, 2023

  Targeting KRAS G12C Cancer Mutations

  Charles H. Weaver, MD

• 

  August 28, 2023

  ctDNA May Help Determine Role of Adjuvant Chemotherapy for Individuals with Sarcoma

  Charles H. Weaver, MD

• 

  June 16, 2023

  July is Sarcoma Awareness Month

  Charles H. Weaver, MD

• 

  December 13, 2022

  FDA Approves Tecentriq for Alveolar Soft Part Sarcoma

  Charles H. Weaver, MD

• 

  September 19, 2022

  SNK01 Yields Sustained Remission in Advanced Sarcoma

  Charles H. Weaver, MD

• 

  June 14, 2022

  Metastatic Ewing’s Sarcoma

  Charles H. Weaver, MD

• 

  June 20, 2021

  Afami-cel Elicits Durable Response Rates in Patients with Sarcoma

  Charles H. Weaver, MD

• 

  December 1, 2020

  Sarcoma Centers Provide The Best Treatment and Access to Clinical Trials

  Charles H. Weaver, MD